Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?
Biomarkers
antidepressants
bipolar disorder
lncRNA
major depressive disorder
miRNA
mood disorders
mood stabilisers
Journal
Non-coding RNA
ISSN: 2311-553X
Titre abrégé: Noncoding RNA
Pays: Switzerland
ID NLM: 101652294
Informations de publication
Date de publication:
24 Aug 2020
24 Aug 2020
Historique:
received:
25
06
2020
revised:
20
08
2020
accepted:
20
08
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
The similarities between the depressive symptoms of Major Depressive Disorders (MDD) and Bipolar Disorders (BD) suggest these disorders have some commonality in their molecular pathophysiologies, which is not apparent from the risk genes shared between MDD and BD. This is significant, given the growing literature suggesting that changes in non-coding RNA may be important in both MDD and BD, because they are causing dysfunctions in the control of biochemical pathways that are affected in both disorders. Therefore, understanding the changes in non-coding RNA in MDD and BD will lead to a better understanding of how and why these disorders develop. Furthermore, as a significant number of individuals suffering with MDD and BD do not respond to medication, identifying non-coding RNA that are altered by the drugs used to treat these disorders offer the potential to identify biomarkers that could predict medication response. Such biomarkers offer the potential to quickly identify patients who are unlikely to respond to traditional medications so clinicians can refocus treatment strategies to ensure more effective outcomes for the patient. This review will focus on the evidence supporting the involvement of non-coding RNA in MDD and BD and their potential use as biomarkers for treatment response.
Identifiants
pubmed: 32846922
pii: ncrna6030033
doi: 10.3390/ncrna6030033
pmc: PMC7549354
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Neuropsychopharmacology. 2017 Mar;42(4):864-875
pubmed: 27577603
Arch Gen Psychiatry. 2003 May;60(5):497-502
pubmed: 12742871
Br J Psychiatry. 1989 Sep;155:294-304
pubmed: 2692760
BMJ. 2007 Feb 3;334(7587):242
pubmed: 17164297
J Affect Disord. 2019 Aug 1;255:10-14
pubmed: 31125858
Genome Med. 2014 Apr 28;6(4):29
pubmed: 24944580
Cell. 2009 Feb 20;136(4):642-55
pubmed: 19239886
Hautarzt. 2014 Dec;65(12):1056-61
pubmed: 25376619
Cancer Cell Int. 2020 Jul 18;20:324
pubmed: 32694946
J Affect Disord. 2019 Apr 15;249:169-174
pubmed: 30772744
Chromosoma. 2017 Oct;126(5):541-557
pubmed: 28593374
Curr Opin Psychiatry. 2018 Jan;31(1):7-16
pubmed: 29076893
Psychol Med. 2015;45(12):2557-69
pubmed: 25817407
ACS Chem Neurosci. 2014 Jun 18;5(6):459-67
pubmed: 24786695
Neuropsychopharmacology. 2020 Mar;45(4):656-665
pubmed: 31775160
Sci Rep. 2020 Mar 25;10(1):5373
pubmed: 32214121
PLoS Biol. 2004 Nov;2(11):e363
pubmed: 15502875
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
pubmed: 11240971
Prog Neurobiol. 2020 Feb;185:101732
pubmed: 31816349
Acta Naturae. 2017 Oct-Dec;9(4):13-25
pubmed: 29340213
Transl Psychiatry. 2018 Oct 18;8(1):224
pubmed: 30337518
Neuron. 2020 Jun 17;106(6):912-926.e5
pubmed: 32304628
Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):315-323
pubmed: 28190298
CNS Drugs. 2017 Apr;31(4):253-262
pubmed: 28290081
Acta Psychiatr Scand. 2011 Dec;124(6):497
pubmed: 22077848
Transl Psychiatry. 2016 Aug 02;6(8):e862
pubmed: 27483380
Front Genet. 2012 Dec 18;3:293
pubmed: 23264780
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
J Affect Disord. 2020 Jan 1;260:97-104
pubmed: 31493646
Biomed Pharmacother. 2018 May;101:663-669
pubmed: 29518613
J Mol Biol. 2013 Oct 9;425(19):3723-30
pubmed: 23178169
Mol Psychiatry. 2015 May;20(5):573-84
pubmed: 25623948
Mol Neurobiol. 2015;51(3):1452-61
pubmed: 25081587
Int J Mol Sci. 2019 Nov 30;20(23):
pubmed: 31801218
CNS Neurol Disord Drug Targets. 2019;18(1):19-28
pubmed: 30398124
Med Sci Monit. 2016 Dec 31;22:5240-5248
pubmed: 28039689
Int J Neuropsychopharmacol. 2015 Apr 21;18(10):pyv042
pubmed: 25899066
Bipolar Disord. 2017 Aug;19(5):396-400
pubmed: 28544121
J Clin Psychiatry. 1998;59 Suppl 15:35-41
pubmed: 9786309
Am J Psychiatry. 2014 Apr;171(4):426-35
pubmed: 24525762
Semin Cell Dev Biol. 2014 Oct;34:9-14
pubmed: 24965208
J Psychiatr Res. 2015 Oct;69:67-71
pubmed: 26343596
J Psychiatr Res. 2016 Jul;78:65-71
pubmed: 27078210
Expert Rev Neurother. 2019 Jan;19(1):67-81
pubmed: 30451546
J Biol Regul Homeost Agents. 2020 Apr 29;34(2):
pubmed: 32351100
J Psychiatr Res. 2014 Dec;59:45-52
pubmed: 25201637
Clin Pharmacol Ther. 2012 Feb;91(2):333-8
pubmed: 22205198
Transl Psychiatry. 2020 Mar 16;10(1):95
pubmed: 32179735
Eur Neuropsychopharmacol. 2013 Jul;23(7):602-11
pubmed: 22925464
J Affect Disord. 2017 Jan 15;208:218-222
pubmed: 27792966
Transl Psychiatry. 2015 Feb 03;5:e504
pubmed: 25646593
Sci Adv. 2017 Sep 27;3(9):eaao2110
pubmed: 28959731
J Integr Neurosci. 2018;17(2):125-132
pubmed: 29036835
J Affect Disord. 2020 Jan 15;261:84-90
pubmed: 31605836
Biochem Biophys Res Commun. 2019 Apr 2;511(2):440-446
pubmed: 30808545
J Affect Disord. 2015 Jun 1;178:25-31
pubmed: 25779937
Neurobiol Aging. 2014 Jan;35(1):152-8
pubmed: 23962497
Indian J Psychiatry. 2017 Jan-Mar;59(1):83-87
pubmed: 28529365
Psychol Med. 2019 Jul;49(10):1691-1704
pubmed: 30178722
Transl Psychiatry. 2012 Nov 13;2:e185
pubmed: 23149449
J Affect Disord. 2016 Jan 15;190:241-248
pubmed: 26521087
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):
pubmed: 25609598
J Affect Disord. 2018 Feb;227:745-751
pubmed: 29689690
J Affect Disord. 2012 Feb;136(3):1232-7
pubmed: 22036795
PLoS One. 2013 Dec 17;8(12):e82895
pubmed: 24358235
PLoS One. 2013;8(1):e48814
pubmed: 23382797
Anticancer Res. 2016 Apr;36(4):1605-11
pubmed: 27069137
Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):893-900
pubmed: 31422452
Neuropsychopharmacology. 2009 May;34(6):1395-405
pubmed: 18704095
Cell Rep. 2018 Oct 30;25(5):1346-1358
pubmed: 30380423
Acta Psychiatr Scand. 1979 Sep;60(3):279-86
pubmed: 495169
Nat Rev Neurosci. 2006 Dec;7(12):911-20
pubmed: 17115073
CNS Drugs. 2013 Feb;27(2):135-53
pubmed: 23371914
J Neurosci. 2016 Jul 6;36(27):7253-67
pubmed: 27383599
Int J Mol Med. 2018 Jan;41(1):493-500
pubmed: 29115444
Int J Mol Med. 2020 Aug;46(2):571-582
pubmed: 32468021
Science. 2018 Feb 9;359(6376):693-697
pubmed: 29439242
Neuromolecular Med. 2014 Dec;16(4):872-7
pubmed: 25149854
Med Sci Monit. 2018 Jun 29;24:4465-4473
pubmed: 29955033
J Psychiatr Res. 2011 Jan;45(1):92-5
pubmed: 20546789
Genomics Proteomics Bioinformatics. 2016 Apr;14(2):73-80
pubmed: 27163185
Ann Neurosci. 2016 Mar;23(1):3-5
pubmed: 27536015
Sci Rep. 2019 Dec 4;9(1):18261
pubmed: 31797941
RNA. 2003 Oct;9(10):1274-81
pubmed: 13130141
Hum Genet. 2017 Feb;136(2):263-274
pubmed: 28035465
Genes (Basel). 2019 Nov 19;10(11):
pubmed: 31752442
NPJ Schizophr. 2018 Feb 20;4(1):4
pubmed: 29463818
Acta Psychiatr Scand. 1990 May;81(5):401-8
pubmed: 2192540
Int J Mol Sci. 2017 Dec 08;18(12):
pubmed: 29292750
J Affect Disord. 2020 Feb 1;262:99-107
pubmed: 31726266
Nat Neurosci. 2015 May;18(5):698-707
pubmed: 25821909
Aust N Z J Psychiatry. 2019 Dec;53(12):1189-1198
pubmed: 31238704
Clin Biochem. 2019 Oct;72:52-57
pubmed: 31437430
Braz J Med Biol Res. 2018;51(7):e7212
pubmed: 29791588
PLoS One. 2018 May 10;13(5):e0197329
pubmed: 29746584
Schizophr Bull. 2011 Jan;37(1):14-20
pubmed: 21149852
Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):335-341
pubmed: 28371072
Exp Neurobiol. 2016 Dec;25(6):296-306
pubmed: 28035180
Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):867-74
pubmed: 27177356
J Affect Disord. 2015 Feb 1;172:96-102
pubmed: 25451401
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:87-103
pubmed: 27072377
Nat Med. 2014 Jul;20(7):764-8
pubmed: 24908571
J Affect Disord. 2016 Aug;200:250-8
pubmed: 27152760
Sci Rep. 2020 Jan 24;10(1):1131
pubmed: 31980721
Transl Psychiatry. 2015 Nov 17;5:e682
pubmed: 26575223
J Affect Disord. 2016 Apr;194:109-14
pubmed: 26807671
Schizophr Res. 2010 Jun;119(1-3):219-27
pubmed: 20347265
J Psychiatr Res. 2016 Nov;82:58-67
pubmed: 27468165
Mol Psychiatry. 2008 Aug;13(8):772-85
pubmed: 17938638
Psychiatr Clin North Am. 2004 Mar;27(1):19-36, vii-viii
pubmed: 15062628
Brain Behav. 2017 May 02;7(6):e00711
pubmed: 28638716
J Res Med Sci. 2018 Aug 23;23:69
pubmed: 30181751
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Int Clin Psychopharmacol. 2014 Jul;29(4):185-96
pubmed: 24424469
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1617-27
pubmed: 18538910
PLoS One. 2012;7(7):e41561
pubmed: 22859996
Arch Gen Psychiatry. 2009 Jul;66(7):748-55
pubmed: 19581566
Exp Mol Pathol. 2014 Oct;97(2):298-304
pubmed: 25102298
PLoS One. 2015 Mar 12;10(3):e0121975
pubmed: 25763923
J Psychiatr Res. 2015 Mar;62:48-55
pubmed: 25708817
Cells. 2019 Jun 27;8(7):
pubmed: 31252530
Alzheimers Res Ther. 2013 Mar 07;5(2):10
pubmed: 23470193
Hum Genomics. 2019 Sep 13;13(1):50
pubmed: 31519209
Int J Neuropsychopharmacol. 2009 Aug;12(7):975-81
pubmed: 19254429
Eur Neuropsychopharmacol. 2020 May;34:39-49
pubmed: 32241689
PLoS One. 2010 Jun 15;5(6):e11109
pubmed: 20559549
Psychol Bull. 1987 Mar;101(2):259-82
pubmed: 3562707
Neuron. 2014 Jul 16;83(2):344-360
pubmed: 24952960
Epidemiol Psychiatr Sci. 2019 Oct 25;29:e63
pubmed: 31648654
Noncoding RNA. 2018 Apr 12;4(2):
pubmed: 29657307
PLoS One. 2011;6(12):e28730
pubmed: 22194897
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):121-5
pubmed: 21677237
Schizophr Bull. 2007 Jul;33(4):886-92
pubmed: 17562693
Scand J Immunol. 2017 Dec;86(6):479-485
pubmed: 29032575
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):417-425
pubmed: 28764913
Cell Cycle. 2008 Nov 15;7(22):3564-76
pubmed: 19001869
Transl Neurodegener. 2016 Mar 15;5:6
pubmed: 26981236
Bipolar Disord. 2011 May;13(3):238-49
pubmed: 21676127
J Psychiatr Res. 2019 Apr;111:110-120
pubmed: 30716647
Neurosci Lett. 2017 Jul 27;654:117-119
pubmed: 28647289
Neurosci Lett. 2019 Mar 23;696:206-211
pubmed: 30599263
J Psychiatr Res. 2019 Oct;117:92-99
pubmed: 31351391